Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
The Global Dental Device Market to hit $12.7 Billion by 2020 Propelled by a Surge in Oral Diseases and Poor Oral Hygiene: ABMRG PR Newswire LONDON and NEW YORK, December 9, 2014 LONDON and NEW...
Linden Capital Partners Completes Acquisition of Young Innovations, Inc. /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; }...
Young Innovations Announces Shareholder Approval of Merger with Affiliates of Linden Capital Partners /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black;...
Young Innovations Announces Expiration of "Go-Shop" Period /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li...
Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (“Young Innovations” or the “Company”) (NasdaqGS: YDNT) for possible breaches of fiduciary...
Young Innovations Announces Date of Special Meeting of Shareholders, Early Termination of Hart-Scott-Rodino Waiting Period and Preliminary Results of Go-Shop Process /* Style Definitions...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc. (CBOU) and Somaxon Pharmaceuticals...
Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals, Inc. and Young Innovations, Inc. /* Style Definitions...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Intermec Inc. (IN), Somaxon Pharmaceuticals, Inc. (SOMX), Clearwire Corp. (CLWR) and Young Innovations, Inc. (YDNT) /...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
